PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Jul-2025 Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions Er-Kim
01-Jul-2025 Camgenium’s Medical Device is Supporting Pregnant Women at Risk of Pre-Eclampsia Camgenium
01-Jul-2025 Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa Formycon AG
01-Jul-2025 Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan) Sobi
01-Jul-2025 Senzime Secures Major U.S. Hospital Contract for Supply and Scientific Collaboration ACCESS Newswire
01-Jul-2025 New Horizon Medical Solutions Adds AmchoPlast(TM) to its Industry-Best Product Portfolio ACCESS Newswire
01-Jul-2025 UN-Affiliated Health Organization Engages Dr. Anosh Ahmed to Develop COVID Testing and Vaccination Standards for Northern Africa ACCESS Newswire
01-Jul-2025 CS Group Announces Strategic MOU Between CS Interpharm and Gulf Center Group for Customized Manufacturing Collaboration ACCESS Newswire
01-Jul-2025 Tekton Research Partners With Summit Clinical Research to Expand Into MASH/NASH Trials ACCESS Newswire
01-Jul-2025 Carthera receives EMA expert panel endorsement for Orphan Medical Device status of SonoCloud system Andrew Lloyd Associates
01-Jul-2025 Iksuda Therapeutics receives FDA IND clearance for IKS014 Iksuda Therapeutics
01-Jul-2025 PharmaForceIQ Announces Substantial Growth as it Expands Optichannel Engagement Solutions PharmaForceIQ
01-Jul-2025 Interactive Strength Inc. (Nasdaq: TRNR) Completes Acquisition of Wattbike, Creating a Diversified Global Fitness Platform on Track for More than $75 Million in Pro Forma 2025 Revenue ACCESS Newswire
01-Jul-2025 Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides Veranova
01-Jul-2025 Imagene AI Hits $45M in Total Funding After Completing $23M Series B Led by Larry Ellison ACCESS Newswire
01-Jul-2025 180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets ACCESS Newswire
01-Jul-2025 Dark Genome Therapeutics Market Size to Reach USD 11,945.7 Million in 2032 Navistrat Analytics
01-Jul-2025 Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB AG
01-Jul-2025 The Increasing Value Of The In-vitro Lung Model Market By 2035 VMR
01-Jul-2025 There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate ACCESS Newswire